ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Evaluation of the Regulatory Effect of the Pan-PPAR Agonist Chiglitazar on the Dawn Phenomenon.

Wenxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.